Toddalolactone inhibits the activation of fibroblasts in skin fibrosis by regulating MAOA

Skin fibrosis is characterized by excessive deposition of extracellular matrix driven by activated fibroblasts, leading to varying degrees of patient discomfort, deformity, disability, and even death. In vitro studies using mouse primary skin fibroblasts (PSFs) and patient-derived primary keloid fibroblasts (KFs) demonstrated that toddalolactone (Tod) significantly inhibited fibroblast proliferation, migration, and activation and suppressed the TGF-β1/Smad and TGF-β1/non-Smad pathways in these cells. In a bleomycin (BLM)-induced mouse model of skin fibrosis, Tod treatment significantly reduced dermal thickness and collagen deposition in mouse skin, decreased skin hydroxyproline content, and inhibited fibroblast activation as well as the TGF-β1/Smad and TGF-β1/non-Smad pathways in vivo. In a keloid xenograft mouse model, Tod treatment significantly reduced the relative weight of keloids in mice. Histopathological analysis revealed that Tod alleviated the degree of keloid fibrosis and collagen aggregation while inhibiting fibroblast activation in keloid tissue. Furthermore, molecular docking identified monoamine oxidase A (MAOA) as a potential target of Tod. Cellular thermal shift assays and MAOA knockdown using siRNA in PSFs and KFs demonstrated that Tod inhibits the TGF-β1 pathway and suppresses fibroblast activation by inhibiting MAOA. Collectively, the findings reveal that Tod regulates the TGF-β1/Smad and TGF-β1/non-Smad pathways through inhibiting MAOA, thereby affecting skin fibroblast activation and alleviating skin fibrosis.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pone.0362493
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Toddalolactone inhibits the activation of fibroblasts in skin fibrosis by regulating MAOA

Hao Song, Cheng Yang, Shimeng Li, 王勇平
1 links
PLoS ONE
Dermatologic Treatments and Research
article

Toddalolactone inhibits the activation of fibroblasts in skin fibrosis by regulating MAOA

Hao Song, Cheng Yang, Shimeng Li, 王勇平
article en

Abstract

Skin fibrosis is characterized by excessive deposition of extracellular matrix driven by activated fibroblasts, leading to varying degrees of patient discomfort, deformity, disability, and even death. In vitro studies using mouse primary skin fibroblasts (PSFs) and patient-derived primary keloid fibroblasts (KFs) demonstrated that toddalolactone (Tod) significantly inhibited fibroblast proliferation, migration, and activation and suppressed the TGF-β1/Smad and TGF-β1/non-Smad pathways in these cells. In a bleomycin (BLM)-induced mouse model of skin fibrosis, Tod treatment significantly reduced dermal thickness and collagen deposition in mouse skin, decreased skin hydroxyproline content, and inhibited fibroblast activation as well as the TGF-β1/Smad and TGF-β1/non-Smad pathways in vivo. In a keloid xenograft mouse model, Tod treatment significantly reduced the relative weight of keloids in mice. Histopathological analysis revealed that Tod alleviated the degree of keloid fibrosis and collagen aggregation while inhibiting fibroblast activation in keloid tissue. Furthermore, molecular docking identified monoamine oxidase A (MAOA) as a potential target of Tod. Cellular thermal shift assays and MAOA knockdown using siRNA in PSFs and KFs demonstrated that Tod inhibits the TGF-β1 pathway and suppresses fibroblast activation by inhibiting MAOA. Collectively, the findings reveal that Tod regulates the TGF-β1/Smad and TGF-β1/non-Smad pathways through inhibiting MAOA, thereby affecting skin fibroblast activation and alleviating skin fibrosis.

PLoS ONEVol. 21(11)
Tianjin University (CN), Nankai University (CN)
National Natural Science Foundation of China, Higher Education Discipline Innovation Project
Good health and well-being
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon